Welcome to LookChem.com Sign In|Join Free
  • or
(E)-(S)-4-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-6-(trityl-carbamoyl)-hex-2-enoic acid ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

199006-04-7

Post Buying Request

199006-04-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

199006-04-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 199006-04-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,0,0 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 199006-04:
(8*1)+(7*9)+(6*9)+(5*0)+(4*0)+(3*6)+(2*0)+(1*4)=147
147 % 10 = 7
So 199006-04-7 is a valid CAS Registry Number.

199006-04-7Relevant academic research and scientific papers

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids

Dragovich, Peter S.,Webber, Stephen E.,Prins, Thomas J.,Zhou, Ru,Marakovits, Joseph T.,Tikhe, Jayashree G.,Fuhrman, Shella A.,Patick, Amy K.,Matthews, David A.,Ford, Clifford E.,Brown, Edward L.,Binford, Susan L.,Meador III, James W.,Ferre, Rose Ann,Worland, Stephen T.

, p. 2189 - 2194 (1999)

Tripeptide-derived molecules incorporating N-methyl amino acid residues and C-terminal Michael acceptor moieties were evaluated as irreversible inhibitors of the cysteine-containing human rhinovirus 3C protease (3CP). Such compounds displayed good 3CP inh

Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides

Dragovich, Peter S.,Zhou, Ru,Skalitzky, Donald J.,Fuhrman, Shella A.,Patick, Amy K.,Ford, Clifford E.,Meador III, James W.,Worland, Stephen T.

, p. 589 - 598 (2007/10/03)

The optimization of a series of irreversible human rhinovirus (HRV) 3C protease (3CP) inhibitors is described. These inhibitors are comprised of an l-Leu-l-Phe-l-Gln tripeptide containing an N-terminal amide moiety and a C-terminal ethyl propenoate Michae

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 199006-04-7